Yew Bio-Pharm Group Inc (YEWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,465 | 986 | -1,322 | 3,213 | 2,007 |
| Depreciation Amortization | 2,817 | 1,827 | 755 | 3,747 | 8,931 |
| Accounts receivable | -776 | -1,689 | 18,511 | -8,554 | -12,260 |
| Accounts payable and accrued liabilities | -114 | -120 | -236 | -2,933 | 3,435 |
| Other Working Capital | 2,291 | 2,742 | 12,822 | -10,290 | -12,826 |
| Other Operating Activity | 11,657 | 8,208 | 1,937 | 12,196 | 11,357 |
| Operating Cash Flow | $17,340 | $11,954 | $32,467 | $-2,620 | $643 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,649 | -13 | -44 | N/A | -62 |
| Purchase Sale Intangibles | -12,707 | -14,656 | -32,757 | -799 | N/A |
| Other Investing Activity | -12,707 | -14,656 | -32,757 | -799 | 296 |
| Investing Cash Flow | $-17,356 | $-14,669 | $-32,800 | $-799 | $235 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 11,814 | 11,905 | 9,013 | 10,940 | 1,809 |
| Debt Issued | 106 | 89 | N/A | N/A | 0 |
| Debt Repayment | N/A | -30 | N/A | N/A | -49 |
| Common Stock Issued | N/A | N/A | 40 | N/A | N/A |
| Other Financing Activity | -11,934 | -9,060 | -9,027 | -7,016 | -3,022 |
| Financing Cash Flow | $-15 | $2,905 | $26 | $3,925 | $-1,262 |
| Exchange Rate Effect | -148 | 31 | -31 | 76 | -19 |
| Beginning Cash Position | 742 | 522 | 860 | 279 | 682 |
| End Cash Position | 564 | 742 | 522 | 860 | 279 |
| Net Cash Flow | $-179 | $221 | $-338 | $581 | $-403 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,340 | 11,954 | 32,467 | -2,620 | 643 |
| Capital Expenditure | -4,649 | -26 | -44 | N/A | -62 |
| Free Cash Flow | 12,691 | 11,928 | 32,424 | -2,620 | 582 |